A1C Level and Future Risk of Diabetes: A Systematic Review
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
We examined ranges of A1C useful for identifying persons at high risk for diabetes prior to preventive intervention by conducting a systematic review. From 16 included studies, we found that annualized diabetes incidence ranged from 0.1% at A1C <5.0% to 54.1% at A1C >or=6.1%. Findings from 7 studies that examined incident diabetes across a broad range of A1C categories showed 1) risk of incident diabetes increased steeply with A1C across the range of 5.0 to 6.5%; 2) the A1C range of 6.0 to 6.5% was associated with a highly increased risk of incident diabetes, 25 to 50% incidence over 5 years; 3) the A1C range of 5.5 to 6.0% was associated with a moderately increased relative risk, 9 to 25% incidence over 5 years; and 4) the A1C range of 5.0 to 5.5% was associated with an increased incidence relative to those with A1C <5%, but the absolute incidence of diabetes was less than 9% over 5 years. Our systematic review demonstrated that A1C values between 5.5 and 6.5% were associated with a substantially increased risk for developing diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“As with the glucose measures, several prospective studies that used A1C to predict the progression to diabetes as de fi ned by A1C criteria demonstrated a strong, continuous association between A1C and subsequent diabetes.”
From 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2024 (2024) · cites this paper as [81]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Those with an A1C range of 6.0 -6.5% (42 -48 mmol/mol) had a 5-year risk of developing diabetes between 25% and 50% and a relative risk 20 times higher than that with A1C of 5.0% (31 mmol/mol) (81).”
From 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2024 (2024) · cites this paper as [81]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Studies suggest that the risk of diabetes development on the basis of FPG and 2-h postload glucose is broadly similar to that posed by A1c.14,18”
From Prediabetes: a high-risk state for diabetes development (2012) · cites this paper as [18]
The cited source says what the claim attributes to it.
In the citing paper
“Similar to glucose measurements, the continuum of risk is continuous: as A1C rises, the diabetes risk rises disproportionately (81).”
From 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2024 (2024) · cites this paper as [81]
The cited source says what the claim attributes to it.
In the citing paper
“In a systematic review of 44,203 individuals from 16 cohort studies with a follow-up interval averaging 5.6 years (range 2.8 -12 years), those with A1C between 5.5% and 6.0% (between 37 and 42 mmol/mol) had a substantially increased risk of diabetes (5-year incidence from 9% to 25%).”
From 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2024 (2024) · cites this paper as [81]
6 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873
Cox, D. R., & Oakes, D. (2018) · Chapman & Hall/CRC eBooks · doi:10.1201/9781315137438 · Cited by 6,234
Breslow, N., Cox, D. R., & Oakes, D. (1985) · Biometrics · doi:10.2307/2530888 · Cited by 4,333
International Expert Committee report on the role of the A1c assay in the diagnosis of diabetes
The International Expert Committee (2009) · Diabetes Care · doi:10.2337/dc09-9033 · Cited by 3,185
Ramachandran, A., Snehalatha, C., Mary, S., Mukesh, B., Bhaskar, A. D., Vijay, V., & Indian Diabetes Prevention Programme (IDPP) (2006) · Diabetologia · doi:10.1007/s00125-005-0097-z · Cited by 1,881
Translating the A1C assay into estimated average glucose values
Nathan, D. M., Kuenen, J., Borg, R., Zheng, H., Schoenfeld, D., Heine, R. J., & for the A1c-Derived Average Glucose (ADAG) Study Group (2008) · Diabetes Care · doi:10.2337/dc08-0545 · Cited by 1,812
Gerstein, H. C., Santaguida, P., Raina, P., Morrison, K. M., Balion, C., Hunt, D., Yazdi, H., & Booker, L. (2007) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2007.05.004 · Cited by 575 · cited 1×
“The progression of risk of diabetes with A1C is similar in magnitude and shape as previously described for fasting plasma glucose and 2-h glucose and suggests that A1C may have a similar application as an indicator of future risk (27).”
BackgroundRelationship between glycated haemoglobin levels and mean glucose levels over time
Nathan, D. M., Turgeon, H., & Regan, S. (2007) · Diabetologia · doi:10.1007/s00125-007-0803-0 · Cited by 517 · cited 1×
“A1C better reflects long-term glycemic exposure than current diagnostic tests based on point-intime measures of fasting and postload blood glucose (4,5) and has improved test-retest reliability (6).”
BackgroundShort-term variability in measures of glycemia and implications for the classification of diabetes
Selvin, E. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.14.1545 · Cited by 402 · cited 1×
“A1C better reflects long-term glycemic exposure than current diagnostic tests based on point-intime measures of fasting and postload blood glucose (4,5) and has improved test-retest reliability (6).”
Background
Research works printed but not linked: 1
- Clarke, 2001, Cochrane Reviewers Handbook
Cited by
Diagnosis and classification of diabetes mellitus
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc14-s081 · Cited by 5,974
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s002 · Cited by 4,792
“betes risk rises disproportionately (84).”
BackgroundStandards of medical care in diabetes—2014
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc14-s014 · Cited by 4,572
“measurements, the continuum of risk is curvilinear, so as A1C rises, the diabetes risk rises disproportionately (15).”
BackgroundStandards of medical care in diabetes—2013
American Diabetes Association (2013) · Diabetes Care · doi:10.2337/dc13-s011 · Cited by 4,369
“As with glucose measurements, the continuum of risk is curvilinear, so that as A1C rises, the risk of diabetes rises disproportionately (15).”
Background2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2020
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s002 · Cited by 3,187
“Similar to glucose measurements, the continuum of risk is curvilinear, so as A1C rises, the diabetes risk rises disproportionately (49).”
Background2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2018
American Diabetes Association (2018) · Diabetes Care · doi:10.2337/dc18-s002 · Cited by 3,159
“Similar to glucose measurements, the continuum of risk is curvilinear, so as A1C rises, the diabetes risk rises disproportionately (26).”
Background2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2021
American Diabetes Association (2021) · Diabetes Care · doi:10.2337/dc21-s002 · Cited by 3,116
“Definition For many years, GDMwas defined as any degree of glucose intolerance that was first recognized during pregnancy (60), regardless of the degree of hyperglycemia.”
BackgroundPrediabetes: a high-risk state for diabetes development
Tabák, A. G., Herder, C., Rathmann, W., Brunner, E. J., & Kivimäki, M. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60283-9 · Cited by 2,958
Standards of medical care in diabetes—2011
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc11-s011 · Cited by 2,880
2. Classification and Diagnosis of Diabetes:Standards of Medical Care in Diabetes—2019
American Diabetes Association (2019) · Diabetes Care · doi:10.2337/dc19-s002 · Cited by 2,697
2. Classification and Diagnosis of Diabetes:Standards of Care in Diabetes—2023
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Gaglia, J. L., Hilliard, M. E., Isaacs, D., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s002 · Cited by 2,433
Diagnosis and classification of diabetes mellitus
American Diabetes Association (2013) · Diabetes Care · doi:10.2337/dc13-s067 · Cited by 2,245
Standards of Medical Care in Diabetes—2012
(2012) · Diabetes Care · doi:10.2337/dc12-s011 · Cited by 2,240
“As with glucose measurements, the continuum of risk is curvilinear, so that as A1C rises the risk of diabetes rises disproportionately (14).”
BackgroundThe worldwide epidemiology of type 2 diabetes mellitus—present and future perspectives
Chen, L., Magliano, D. J., & Zimmet, P. Z. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.183 · Cited by 2,227
“Among individuals without T2DM, increasing HbA 1c level is associated with not only future risk of T2D”
Background2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2024
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Gaglia, J. L., Hilliard, M. E., Johnson, E. L., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s002 · Cited by 2,086
(2) Classification and diagnosis of diabetes
American Diabetes Association (2015) · Diabetes Care · doi:10.2337/dc15-s005 · Cited by 1,841
“of risk is curvilinear, so as A1C rises, the diabetes risk rises disproportionately (12).”
Background2. Classification and Diagnosis of Diabetes
American Diabetes Association (2017) · Diabetes Care · doi:10.2337/dc17-s005 · Cited by 1,603
“of risk is curvilinear, so as A1C rises, the diabetes risk rises disproportionately (12).”
Background2. Diagnosis and classification of diabetes: standards of care in diabetes-2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Ebekozien, O., Echouffo-Tcheugui, J. B., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s002 · Cited by 1,393
Diabetes mellitus: The epidemic of the century
Kharroubi, A. T. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i6.850 · Cited by 1,229
2. Classification and Diagnosis of Diabetes
American Diabetes Association (2016) · Diabetes Care · doi:10.2337/dc16-s005 · Cited by 1,066
“tinuumof risk is curvilinear, so asA1C rises, the diabetes risk rises disproportionately (12).”
BackgroundDefinition, Classification and Diagnosis of Diabetes, Prediabetes and Metabolic Syndrome
Punthakee, Z., Goldenberg, R., & Katz, P. (2018) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.10.003 · Cited by 877
“0% can indeed be associated with an increased risk for diabetes (50).”
BackgroundType 2 diabetes mellitus in adults: pathogenesis, prevention and therapy
Lu, X., Xie, Q., Pan, X., Zhang, R., Zhang, X., Peng, G., Zhang, Y., Shen, S., & Tong, N. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01951-9 · Cited by 665
Self-citationDefinition, Classification and Diagnosis of Diabetes, Prediabetes and Metabolic Syndrome
Goldenberg, R., & Punthakee, Z. (2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.01.011 · Cited by 611
2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2026
American Diabetes Association Professional Practice Committee for Diabetes*, Bajaj, M., McCoy, R. G., Balapattabi, K., Bannuru, R. R., Bellini, N. J., Bennett, A. K., Beverly, E. A., Briggs Early, K., ChallaSivaKanaka, S., et al. (2026) · Diabetes Care · doi:10.2337/dc26-s002 · Cited by 473
Peddie, M. C., Bone, J. L., Rehrer, N. J., Skeaff, C. M., Gray, A. R., & Perry, T. L. (2013) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.112.051763 · Cited by 431
Prediabetes and what it means: the epidemiological evidence
Echouffo-Tcheugui, J. B., & Selvin, E. (2021) · Annual Review of Public Health · doi:10.1146/annurev-publhealth-090419-102644 · Cited by 406
Barry, E., Roberts, S., Oke, J., Vijayaraghavan, S., Normansell, R., & Greenhalgh, T. (2017) · BMJ · doi:10.1136/bmj.i6538 · Cited by 330
Kocher, T., König, J., Borgnakke, W. S., Pink, C., & Meisel, P. (2018) · Periodontology 2000 · doi:10.1111/prd.12235 · Cited by 293
Composition Diversity and Abundance of Gut Microbiome in Prediabetes and Type 2 Diabetes
Sr Fellow New Mexico Center for the Advancement of Research, E., Shah, V., Lambeth, S. M., Carson, T., Lowe, J., Ramaraj, T., Leff, J. W., Luo, L., & Bell, C. J. (2015) · Journal of Diabetes and Obesity · doi:10.15436/2376-0949.15.031 · Cited by 287
“4%) have an increased relative risk of developing T2DM in 5-years compared to those with normal levels, and the higher the HbA1C, the greater the risk[4].”
BackgroundInfluence of gender and menopausal status on gut microbiota
Santos-Marcos, J. A., Rangel-Zuñiga, O. A., Jimenez-Lucena, R., Quintana-Navarro, G. M., Garcia-Carpintero, S., Malagon, M. M., Landa, B. B., Tena-Sempere, M., Perez-Martinez, P., Lopez-Miranda, J., et al. (2018) · Maturitas · doi:10.1016/j.maturitas.2018.07.008 · Cited by 287
Development of type 2 diabetes mellitus in people with intermediate hyperglycaemia
Richter, B., Hemmingsen, B., Metzendorf, M.-I., & Takwoingi, Y. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012661.pub2 · Cited by 283
Assessment of Pancreatic β-Cell Function: Review of Methods and Clinical Applications
Cersosimo, E., Solis-Herrera, C., Trautmann, M., Malloy, J., & Triplitt, C. (2014) · Current Diabetes Reviews · doi:10.2174/1573399810666140214093600 · Cited by 281
Heianza, Y., Hara, S., Arase, Y., Saito, K., Fujiwara, K., Tsuji, H., Kodama, S., Hsieh, S. D., Mori, Y., Shimano, H., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60472-8 · Cited by 260
Prediabetes and Lifestyle Modification: Time to Prevent a Preventable Disease
Tuso, P. (2014) · The Permanente Journal · doi:10.7812/tpp/14-002 · Cited by 252
Valerio, G., Maffeis, C., Saggese, G., Ambruzzi, M. A., Balsamo, A., Bellone, S., Bergamini, M., Bernasconi, S., Bona, G., Calcaterra, V., et al. (2018) · Italian Journal of Pediatrics · doi:10.1186/s13052-018-0525-6 · Cited by 225
Inzucchi, S. E. (2012) · New England Journal of Medicine · doi:10.1056/nejmcp1103643 · Cited by 199
López‐Candales, A., Burgos, P. M. H., Hernández-Suárez, D. F., & Harris, D. A. (2017) · PubMed · Cited by 250
The dynamic plasticity of insulin production in β-cells
Boland, B. B., Rhodes, C. J., & Grimsby, J. S. (2017) · Molecular Metabolism · doi:10.1016/j.molmet.2017.04.010 · Cited by 194
Intermuscular adipose tissue is muscle specific and associated with poor functional performance
Tuttle, L. J., Sinacore, D. R., & Mueller, M. J. (2012) · Journal of Aging Research · doi:10.1155/2012/172957 · Cited by 193
“8 which is indicative of people at risk for developing diabetes [27].”
BackgroundJha, R., Lopez-Trevino, S., Kankanamalage, H. R., & Jha, J. C. (2024) · Biomedicines · doi:10.3390/biomedicines12051098 · Cited by 144
“The most widely used technique to diagnose diabetes includes the assessment of the glycated haemoglobin (HbA1c), which can be used as a predictor of diabetes and future complications with high specificity [58,63,64].”
MethodHeidemann, C., Du, Y., Paprott, R., Haftenberger, M., Rathmann, W., & Scheidt‐Nave, C. (2016) · Diabetic Medicine · doi:10.1111/dme.13008 · Cited by 131
Rosenzweig, J. L., Bakris, G. L., Berglund, L. F., Hivert, M.-F., Horton, E. S., Kalyani, R. R., Murad, M. H., & Vergès, B. L. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-01338 · Cited by 126
(2013) · New England Journal of Medicine · doi:10.1056/nejmc1212738 · Cited by 114
Chronic Activation of γ2 AMPK Induces Obesity and Reduces β Cell Function
Yavari, A., Stocker, C. J., Ghaffari, S., Wargent, E. T., Steeples, V., Czibik, G., Pinter, K., Bellahcene, M., Woods, A., Martínez de Morentin, P. B., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.04.003 · Cited by 112
Stanifer, J. W., Cleland, C. R., Makuka, G. J., Egger, J. R., Maro, V. P., Maro, H., Karia, F. P., Patel, U. D., Burton, M. J., & Philippin, H. (2016) · PLoS ONE · doi:10.1371/journal.pone.0164428 · Cited by 132
“9% in the absence of treatment with antihyperglycemic medications were considered to have glucose impairment with an increased risk for developing diabetes [17].”
BackgroundMcCurley, J. L., Gutierrez, A. P., & Gallo, L. C. (2017) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2016.10.028 · Cited by 110
Mechanick, J. I., Garber, A. J., Grunberger, G., Handelsman, Y., & Garvey, W. T. (2018) · Endocrine Practice · doi:10.4158/ps-2018-0139 · Cited by 104
Classification and Diagnosis of Diabetes
GENUTH, S. M., Palmer, J. P., & Nathan, D. M. (2018) · Cited by 112
Parker, A. R., Byham-Gray, L., Denmark, R., & Winkle, P. J. (2014) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2014.07.020 · Cited by 92
Genetic Predisposition Impacts Clinical Changes in a Lifestyle Coaching Program
Zubair, N., Conomos, M. P., Hood, L., Omenn, G. S., Price, N. D., Spring, B. J., Magis, A. T., & Lovejoy, J. C. (2019) · Scientific Reports · doi:10.1038/s41598-019-43058-0 · Cited by 88
Gillies, N. A., Pendharkar, S. A., Asrani, V. M., Mathew, J., Windsor, J. A., & Petrov, M. S. (2016) · Pancreatology · doi:10.1016/j.pan.2016.06.661 · Cited by 87
Lucht, S. A., Hennig, F., Matthiessen, C., Ohlwein, S., Icks, A., Moebus, S., Jöckel, K., Jakobs, H. J., & Hoffmann, B. H. (2018) · Environmental Health Perspectives · doi:10.1289/ehp2561 · Cited by 75
Verier‐Mine, O. (2010) · Diabetes & Metabolism · doi:10.1016/j.diabet.2010.11.011 · Cited by 78
Sinning, C., Makarova, N., Völzke, H., Schnabel, R. B., Ojeda, F., Dörr, M., Felix, S. B., Köenig, W., Peters, A., Rathmann, W., et al. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-021-01413-4 · Cited by 82
“The increasing risk for developing diabetes with increasing HbA1c levels has been reported before [32].”
BackgroundPerreault, L., & Færch, K. (2013) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2013.10.008 · Cited by 92
“(Morris et al. 2013; Zhang et al. 2010).”
Postpartum glucose intolerance: an updated overview
Pastore, I., CHIEFARI, E. D., Vero, R., & Brunetti, A. (2017) · Endocrine · doi:10.1007/s12020-017-1388-0 · Cited by 71
Costa, B., Barrio, F., Piñol, J. L., Cabré, J.-J., Mundet, X., Sagarra-Alamo, R., Salas‐Salvadó, J., & Solà-Morales, O. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-45 · Cited by 93
“While the 2-hour, fasting glucose, and HbA1c can all be defined as continuous statistical variables that are influenced by individual habits, it is not well known which of these variables are best related to the primary risk factors of diabetes [16].”
BackgroundOo, S. M., Misu, H., Saito, Y., Tanaka, M., Kato, S., Kita, Y., Takayama, H., Takeshita, Y., Kanamori, T., Nagano, T., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-35067-2 · Cited by 70
DeJesus, R. S., Breitkopf, C. R., Rutten, L. J., Jacobson, D. J., Wilson, P. M., & Sauver, J. S. (2017) · Population Health Management · doi:10.1089/pop.2016.0067 · Cited by 61
“16,27,28 31 It is likewise well established that baseline glucose level is significantly associated with an increased risk of progression to diabetes 13,32 ; however, the present study results demonstrated that the risk of progression did not vary linearly with the baseline glucose level.”
Cytokine profiling of young overweight and obese female African American adults with prediabetes
Lucas, R., Parikh, S. J., Sridhar, S., Guo, D.-H., Bhagatwala, J., Dong, Y., Caldwell, R. B., Mellor, A. L., Caldwell, W., Zhu, H., et al. (2013) · Cytokine · doi:10.1016/j.cyto.2013.05.025 · Cited by 69
Is Genetic testing useful to predict type 2 diabetes?
Vassy, J. L., & Meigs, J. B. (2012) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2011.09.002 · Cited by 76
Unnikrishnan, R., Shaw, J. E., Chan, J. C. N., Wild, S. H., Peters, A. L., Orrange, S., Roden, M., & Mohan, V. (2025) · Nature Reviews Disease Primers · doi:10.1038/s41572-025-00635-0 · Cited by 76
“In 2010, the American Diabetes Association lowered the range to 5.7–6.4% (39–47 mmol/mol) to better identify individuals with IGT and IFG and those at high risk of cardiovascular disease 218 .”
InfluentialElevated HbA1c and Fasting Plasma Glucose in Predicting Diabetes Incidence Among Older Adults
Lipska, K. J., Inzucchi, S. E., Ness, P. H. V., Gill, T. M., Kanaya, A. M., Strotmeyer, E. S., Koster, A., Johnson, K., Goodpaster, B. H., Harris, T. B., et al. (2013) · Diabetes Care · doi:10.2337/dc12-2631 · Cited by 64
Liew, A., Punnanithinont, N., Lee, Y., & Yang, J. (2013) · Australian Dental Journal · doi:10.1111/adj.12091 · Cited by 71
“Glycated haemoglobin (HbA1c) is often used in clinical settings to monitor average blood glucose levels over the past few months, hence high HbA1c indicates poor glycaemic control.(20)”
BackgroundHeianza, Y., Arase, Y., Hsieh, S. D., Saito, K., Tsuji, H., Kodama, S., Tanaka, S., Ohashi, Y., Shimano, H., Yamada, N., et al. (2012) · Diabetologia · doi:10.1007/s00125-012-2712-0 · Cited by 57
“Since the utility of HbA1c as a screening tool for individuals at risk of diabetes has been recognised [46, 47], it is reasonable that the use of two glycaemic indicators would be considered in developing an effective screening score for risk of diabetes.”
Deschênes, S. S., Burns, R. J., Graham, E. A., & Schmitz, N. (2016) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2016.08.011 · Cited by 58
Silbernagel, G., Grammer, T. B., Winkelmann, B. R., Boehm, B. O., & März, W. (2011) · Diabetes Care · doi:10.2337/dc10-2010 · Cited by 51
Kumar, A., Wong, R., Ottenbacher, K. J., & Snih, S. A. (2016) · Annals of Epidemiology · doi:10.1016/j.annepidem.2015.12.006 · Cited by 54
“Prediabetes is a high-risk state for diabetes development [4,5].”
Karimifard, M., Aminorroaya, A., Kachuei, A., Salamat, M. R., Alijanvand, M. H., Yamini, S. A., Karimifar, M., Feizi, A., & Amini, M. (2018) · Journal of Diabetes Investigation · doi:10.1111/jdi.12944 · Cited by 57
Polonsky, K. S., & Burant, C. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-29738-7.00031-9 · Cited by 73
Classification and Diagnosis of Diabetes
Elliott, T. L., & Pfotenhauer, K. M. (2022) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2021.11.011 · Cited by 57
“of risk is curvilinear, so as A1C rises, the diabetes risk rises disproportionately (12).”
BackgroundMcCurley, J. L., Mills, P. J., Roesch, S. C., Carnethon, M. R., Giacinto, R. E., Isasi, C. R., Teng, Y., Sotres‐Alvarez, D., Llabre, M. M., Penedo, F. J., et al. (2015) · Psychophysiology · doi:10.1111/psyp.12430 · Cited by 56
Lager, C. J., Esfandiari, N. H., Luo, Y., Subauste, A. R., Kraftson, A. T., Brown, M. B., Varban, O. A., Meral, R., Cassidy, R. B., Nay, C. K., et al. (2018) · Obesity Surgery · doi:10.1007/s11695-018-3346-1 · Cited by 53
Impact of Different Criteria on Type 2 Diabetes Remission Rate After Bariatric Surgery
On Behalf of the Obemar Group, Mas-Lorenzo, A., Benaiges, D., Roux, J. A. F., Pedro-Botet, J., Ramón, J. M., Parri, A., Villatoro, M., Chillarón, J. J., Pera, M., et al. (2014) · Obesity Surgery · doi:10.1007/s11695-014-1282-2 · Cited by 51
Lapolla, A., Mosca, A., & Fedele, D. (2011) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2011.02.006 · Cited by 49
“5% with an incidence of <9% [60].”
Diagnóstico do diabetes e rastreamento do diabetes tipo 2
Cobas, R. A., Rodacki, M., Giacaglia, L. R., Calliari, L. E., de Noronha, R. M., Valério, C. M., Custódio, J., Scharf, M., Barcellos, C. R. G., Tomarchio, M. P., et al. (2022) · Conectando Pessoas eBooks · doi:10.29327/557753.2022-2 · Cited by 109
Love-Osborne, K. A., Sheeder, J. L., Nadeau, K. J., & Zeitler, P. (2018) · Pediatric Diabetes · doi:10.1111/pedi.12570 · Cited by 41
“5% (42-48 mmol/mol) was associated with a 25%-50% incidence of type 2 diabetes over 5 years.(7) More recently, a large study that included both youth and adult Pima Indians showed an elevated A1c (>5.”
BackgroundFiorentino, T. V., Sesti, F. F., Andreozzi, F., Pedace, E., Sciacqua, A., Hribal, M. L., Perticone, F., & Sesti, G. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.08.020 · Cited by 43
An increase in inflammation and islet dysfunction is a feature of prediabetes
Weaver, J. R., Odanga, J. J., Breathwaite, E. K., Treadwell, M. L., Murchinson, A. C., Walters, G. D., Fuentes, D. P., & Lee, J. B. (2020) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3405 · Cited by 46
“5% over a 5‐year time period.(3,4) These individuals also have a higher risk of heart failure and stroke.”
BackgroundAlEssa, H. B., Ley, S. H., ROSNER, B. A., Malik, V., Willett, W. C., Campos, H., & Hu, F. B. (2016) · Journal of Nutrition · doi:10.3945/jn.115.219915 · Cited by 43
Huang, M., Que, Y., & Shen, X. (2014) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2014.12.007 · Cited by 42
Zhang, Y. H., Ma, W. J., Thomas, G. N., Xu, Y. J., Lao, X. Q., Xu, X. J., Song, X. L., Xu, H. F., Cai, Q. M., Xia, L., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037260 · Cited by 41
“5% had a substantial increased risk for developing diabetes within 5 years [22,23].”
BackgroundThe role of hemoglobin A1c in the assessment of diabetes and cardiovascular risk
Sandler, C. N., & McDonnell, M. E. (2016) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.83.s1.02 · Cited by 41
“22 The ADA-defi ned lower limit for diagnosing prediabetes (HbA1c ≥ 5.7”
BackgroundInfluentialDNA damage and cytotoxicity in adult subjects with prediabetes
Pereira, C. S., Molz, P., Palazzo, R. P., de Freitas, T. A. B., Maluf, S. W., Horta, J. A., Prá, D., & Franke, S. I. R. (2013) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2013.02.002 · Cited by 42
Davidson, A. J. F., Park, A. L., Berger, H. M., Aoyama, K., Harel, Z., Cook, J. L., & Ray, J. G. (2020) · PLoS Medicine · doi:10.1371/journal.pmed.1003104 · Cited by 40
Definition, Classification and Diagnosis of Diabetes, Prediabetes and Metabolic Syndrome
(2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.02.002 · Cited by 39
Mei, Y., Li, A., Zhao, J., Zhou, Q., Zhao, M., Xu, J., Li, R., Li, Y., Li, K., Ge, X., et al. (2022) · Environmental Research · doi:10.1016/j.envres.2022.114472 · Cited by 38
Low positive predictive value of hemoglobin A1c for diagnosis of prediabetes in clinical practice
Gosmanov, A. R., & Wan, J. (2014) · The American Journal of the Medical Sciences · doi:10.1097/maj.0000000000000223 · Cited by 35
“Some authors explain the lack of consensus on the “diabetogenic” value of HbA1c-based diagnosis of prediabetes by the absence of prospective observational data.(15) Recently, analysis of the Atherosclerosis Risk in Communities Study showed that community-dwelling subjects with a baseline HbA1c of 5.”
BackgroundPrevention of Type 2 Diabetes in U.S. Hispanic Youth: A Systematic Review of Lifestyle Interventions
McCurley, J. L., Crawford, M. A., & Gallo, L. C. (2017) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2017.05.020 · Cited by 37
Review of 2017 Diabetes Standards of Care
Crawford, K. (2017) · Nursing Clinics of North America · doi:10.1016/j.cnur.2017.07.010 · Cited by 41
Tabák, Á. G., Brunner, E. J., Lindbohm, J. V., Singh‐Manoux, A., Shipley, M. J., Sattar, N. A., & Kivimäki, M. (2022) · Circulation · doi:10.1161/circulationaha.122.059430 · Cited by 39
Alternative HbA1c Cutoffs to Identify High-Risk Adults for Diabetes Prevention
Zhuo, X., Zhang, P., Selvin, E., Hoerger, T. J., Ackermann, R. T., Li, R., Bullard, K. M., & Gregg, E. W. (2012) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2012.01.003 · Cited by 35
Self-citationPerayil, J., Suresh, N., Fenol, A., Vyloppillil, R., Bhaskar, A., & Menon, S. (2014) · Journal of Periodontology · doi:10.1902/jop.2014.130661 · Cited by 34
Anderson, K., Wherle, L., Park, M. S., Nelson, K., & Nguyen, L. D. (2014) · Europe PMC (PubMed Central) · Cited by 39
Identification of a New Class of Glucokinase Activators through Structure-Based Design
Hinklin, R. J., Boyd, S. A., Chicarelli, M. J., Condroski, K. R., DeWolf, W. E., Lee, P. A., Lee, W., Singh, A., Thomas, L., Voegtli, W. C., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm401116k · Cited by 33
Prediabetes and diabetes among HIV‐infected adults in Cameroon
Rhee, J. Y., Bahtila, T. D., Palmer, D. J., Tih, P. M., Aberg, J. A., LeRoith, D., & Jao, J. K. (2016) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2792 · Cited by 32
3 D Mitochondrial Structure in Aging Human Skeletal Muscle: Insights Into MFN ‐2‐Mediated Changes
Scudese, E., Marshall, A. G., Vue, Z., Exil, V. J., Rodriguez, B. I., Demirci, M., Vang, L., Lopez, E. G., Neikirk, K., Shao, B., et al. (2025) · Aging Cell · doi:10.1111/acel.70054 · Cited by 38
Marley, J. V., Oh, M. S., Hadgraft, N. T., Singleton, S., Isaacs, K., & Atkinson, D. N. (2015) · BMJ Open · doi:10.1136/bmjopen-2014-006277 · Cited by 35
Butler, A. E., English, E., Kilpatrick, E. S., Östlundh, L., Chemaitelly, H. S., Abu-Raddad, L. J., Alberti, K. G. M. M., Atkin, S. L., & John, W. G. (2020) · Acta Diabetologica · doi:10.1007/s00592-020-01606-5 · Cited by 36
de Carvalho, L. S. F., Benseñor, I. M., Nogueira, A. C. C., Duncan, B. B., Schmidt, M. I., Blaha, M. J., Toth, P. P., Jones, S. R., Santos, R. D., Lotufo, P. A., et al. (2020) · Diabetologia · doi:10.1007/s00125-020-05322-1 · Cited by 30
Metadata
- Authors
- Zhang, X., Gregg, E. W., Williamson, D. F., Barker, L. E., Thomas, W., Bullard, K. M., Imperatore, G., Williams, D. E., & Albright, A. L.
- Affiliations
- Centers for Disease Control and Prevention (US)
- Emory University (US)
- Corresponding author
- Zhang, Xuanping
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2010-07-01
- Volume
- 33
- Issue
- 7
- Pages
- 1665-1673
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2890379
- OpenAlex
- W2137837290
- Cited by
- 422
- References
- 32
- Citations by year
- 2026: 16 · 2025: 31 · 2024: 30 · 2023: 34 · 2022: 28 · 2021: 34 · 2020: 22 · 2019: 22 · 2018: 22 · 2017: 27 · 2016: 27 · 2015: 29 · 2014: 26 · 2013: 29 · 2012: 24
- FWCI
- 3.32
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Spiral (Imperial College London) (submittedVersion, cc-by-nc-nd)
- Funders
- Centers for Disease Control and Prevention
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Keywords
- HbA1c, new-onset diabetes, diabetes risk prediction, prediabetes, diabetes prevention, HbA1c thresholds, diabetes incidence
- MeSH terms
- Diabetes Mellitus, Type 2, Glycated Hemoglobin, Humans, Risk Factors, Incidence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

